Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

The development of well-tolerated and effective therapies that target the pathogenesis of membranous nephropathy (MN) would be useful. Our objective was to evaluate the efficacy of rituximab in MN. We analyzed the outcome of 28 patients treated with rituximab for idiopathic MN. Anti-PLA(2)R antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Pierre-Antoine, Dahan, Karine, Ancel, Pierre-Yves, Plaisier, Emmanuelle, Mojaat, Rachid, De Seigneux, Sophie, Daugas, Eric, Matignon, Marie, Mesnard, Laurent, Karras, Alexandre, François, Hélène, Pardon, Agathe, Caudwell, Valérie, Debiec, Hanna, Ronco, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290855/
https://www.ncbi.nlm.nih.gov/pubmed/22470399
http://dx.doi.org/10.1159/000333068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290855/
https://www.ncbi.nlm.nih.gov/pubmed/22470399
http://dx.doi.org/10.1159/000333068

Ejemplares similares